CluePoints Appoints Usama Dar as Chief Product and Technology Officer

Andy Cooper, CEO at CluePoints, commented: "CluePoints has gone from being a very successful single-product company to a multi-product company undergoing a period of rapid growth, both in terms of people and our platform. Usama is the perfect fit to support us on our journey to provide the most comprehensive, and highest quality, Integrated Data Review platform for the Clinical Development industry." Andy Cooper, CEO at CluePoints,commented:"CluePoints has gone from being a very...

KING OF PRUSSIA, Pa., 01/04/2025 (informazione.news - comunicati stampa - information technology)

commented:

reiterated the opportunities for growth at CluePoints:

added:

To learn more about CluePoints' award-winning solutions, please visit www.cluepoints.com

CluePoints is the premier Risk-Based Quality Management (RBQM) and Data Quality Oversight Software provider. We are leveraging the potential of Artificial Intelligence using Advanced Statistics and Machine Learning to determine the quality, accuracy, and integrity of clinical trial data both during and after study conduct. Aligned with guidance from the FDA, EMA, and ICH E6 (R3), CluePoints is deployed to support central and on-site monitoring, medical review, quality risk management and to drive a holistic Risk-Based strategy in all trials. Coupled with thought leadership and consulting expertise to aid pre-study risk assessment, identification of risk controls and solution implementation, you now have everything you need to adhere with global regulatory guidance. The result is positive clinical development outcomes, increased operational efficiency, lower costs and reduced regulatory submission risk as part of the industry paradigm shift to RBQM.

 

View original content:https://www.prnewswire.co.uk/news-releases/cluepoints-appoints-usama-dar-as-chief-product-and-technology-officer-302416996.html